SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-21-021784
Filing Date
2021-04-15
Accepted
2021-04-15 17:27:52
Documents
9

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 ea139269-posam_abvcbio.htm POS AM 1864771
2 LEGAL OPINION OF HUNTER TAUBMAN FISCHER & LI LLC ea139269ex5-1_abvcbio.htm EX-5.1 11351
3 CONSENT OF KCCW ACCOUNTANCY CORP (FILED HEREWITH) ea139269ex23-2_abvcbio.htm EX-23.2 3796
4 GRAPHIC image_001.jpg GRAPHIC 23958
5 GRAPHIC image_002.jpg GRAPHIC 26957
6 GRAPHIC image_003.jpg GRAPHIC 23913
7 GRAPHIC image_004.jpg GRAPHIC 30224
8 GRAPHIC ex5-1_001.jpg GRAPHIC 6909
9 GRAPHIC image_006.jpg GRAPHIC 4245
  Complete submission text file 0001213900-21-021784.txt   2042009
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-250899 | Film No.: 21829452
SIC: 2834 Pharmaceutical Preparations